16 results on '"Metrangolo P."'
Search Results
2. Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma.
3. P.09.16 LONG-TERM SORAFENIB TREATMENT IN A LARGE COHORT OF HCC PATIENTS: A MULTICENTER STUDY.
4. Adherence to EASL-EORTC clinical guidelines for the management of hepatocellular carcinoma in field practice: Results from the ITALICA database.
5. Efficacy of sorafenib in patients with intermediate-stage hepatocellular carcinoma: results from the ITA.LI.CA. database.
6. P.17.3 EFFICACY OF SORAFENIB ACCORDING TO THE NUMBER OF PRIOR TACE PROCEDURES IN HEPATOCELLULAR CARCINOMA PATIENTS.
7. F-42 Liver perfusion CT for non-invasive assessment of response to sorafenib therapy in patients with advanced HCC: preliminary findings.
8. P.08.20 RAMP-UP STRATEGY AND LONG-TERM RESULTS OF SORAFENIB IN ADVANCED-STAGE HEPATOCELLULAR CARCINOMA IN DAILY CLINICAL PRACTICE CONDITIONS.
9. P.08.12 EARLY ASSESSMENT OF RESPONSE TO SORAFENIB IN ADVANCED HEPATOCELLULAR CARCINOMA USING PERFUSIONAL COMPUTED TOMOGRAPHY: PILOT STUDY.
10. P.06.8 THERAPEUTIC EFFICACY OF GRANULOCYTAPHERESIS IN INFLAMMATORY BOWEL DISEASES: A PROSPECTIVE OBSERVATIONAL STUDY.
11. T-11 Early assessment of response to sorafenib in advanced hepatocellular carcinoma using perfusional computed tomography: pilot study.
12. T-3 Ramp-up strategy and long-term results of sorafenib in advanced-stage hepatocellular carcinoma under daily clinical practice conditions.
13. P.1.275: LONG-TERM RESULTS OF SORAFENIB IN ADVANCED-STAGE HEPATOCELLULAR: WHAT CAN WE LEARN FROM DAILY CLINICAL PRACTICE.
14. P.1.141: GRANULOCYTEAPHERESIS (GCAP) IN INFLAMMATORY BOWEL DISEASES. A PROSPECTIVE, SINGLE CENTER EXPERIENCE.
15. Selective transcatheter arterial chemoembolization for hepatocellular carcinoma: Evaluation of clinical impact-short and long-term prospective study.
16. Integrated microfluidic viscometer for edible oil analysis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.